The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Tepmetko is the first and only oral MET inhibitor to be approved in the European Economic Area for treating adult patients with advanced NSCLC harboring alterations leading to METex14 skipping, who require systemic therapy following prior treatment
These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
